These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32904444)

  • 1. Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study.
    Kong M; Sung JY; Lee SH
    Onco Targets Ther; 2020; 13():8173-8180. PubMed ID: 32904444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.
    Kong M; Sung JY; Lee SH
    Onco Targets Ther; 2019; 12():8263-8273. PubMed ID: 31632076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
    Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
    Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy.
    Kwack WG; Sung JY; Lee SH
    Front Oncol; 2021; 11():770230. PubMed ID: 34956890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study.
    Chang B; Hwang IK; Lee SH
    Onco Targets Ther; 2021; 14():5097-5106. PubMed ID: 34707368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species modulator 1 expression predicts lymph node metastasis and survival in early-stage non-small cell lung cancer.
    Kim T; Cha YJ; Park JH; Kim A; Choi YJ; Park HJ
    PLoS One; 2020; 15(12):e0239670. PubMed ID: 33259495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas.
    Kim TW; Na K; Jung J; Lim H; Seo H; Lee SH
    Oncology; 2024; 102(11):969-978. PubMed ID: 39053443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients.
    Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Kim BH; Yoo YD; Oh SC
    Onco Targets Ther; 2018; 11():4233-4246. PubMed ID: 30087567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
    Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Lee HS; Kim BH; Lee SI; Min BW; Yoo YD; Oh SC
    PLoS One; 2017; 12(5):e0176834. PubMed ID: 28472059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
    Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
    Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
    Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
    J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
    Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
    Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.
    Ghasemi H; Amini MA; Pegah A; Azizi E; Tayebinia H; Khanverdilou S; Mousavibahar SH; Alizamir A
    Mol Biol Rep; 2020 Sep; 47(9):6497-6505. PubMed ID: 32770525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance to 5-FU linked to reactive oxygen species modulator 1.
    Hwang IT; Chung YM; Kim JJ; Chung JS; Kim BS; Kim HJ; Kim JS; Yoo YD
    Biochem Biophys Res Commun; 2007 Jul; 359(2):304-10. PubMed ID: 17537404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease.
    Ye L; Mao S; Fang S; Zhang J; Tan Y; Gu W
    Inflammation; 2019 Oct; 42(5):1555-1560. PubMed ID: 31049771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
    Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romo1 expression contributes to oxidative stress-induced death of lung epithelial cells.
    Shin JA; Chung JS; Cho SH; Kim HJ; Yoo YD
    Biochem Biophys Res Commun; 2013 Sep; 439(2):315-20. PubMed ID: 23867822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.